Policy changes Backwork has recorded, newest first. The most recent change on record is from October 24, 2026. Changes appear here after Backwork reviews and applies a refresh, so this page can trail the payers’ own sites.
Summary of the payer’s published policy. Not a coverage determination — confirm with the payer before submitting.
86,510 on record
| Recorded | Payer | Policy | Change |
|---|---|---|---|
| May 8, 2026 | CMS / Medicare | Response to Comments: MolDX: Pharmacogenomics Testing | Metadata changed |
| May 8, 2026 | CMS / Medicare | Response to Comments: Biomarker Testing (Prior to Initial Biopsy) for Prostate Cancer Diagnosis | Metadata changed |
| May 8, 2026 | CMS / Medicare | Verteporfin | Metadata changed |
| May 8, 2026 | CMS / Medicare | Consultation Services Rendered by a Podiatrist in a Skilled Nursing Facility | Metadata changed |
| May 8, 2026 | CMS / Medicare | Sacroiliac Joint Injections and Procedures | Metadata changed |
| May 8, 2026 | CMS / Medicare | MRI and CT Scans of the Head and Neck | Metadata changed |
| May 8, 2026 | CMS / Medicare | Allergen Immunotherapy (AIT) with Subcutaneous Immunotherapy (SCIT) | Metadata changed |
| May 8, 2026 | CMS / Medicare | Response to Comments: Genomic Sequence Analysis Panels in the Treatment of Hematolymphoid Diseases | Metadata changed |
| May 8, 2026 | CMS / Medicare | MolDX: Molecular Diagnostic Tests (MDT) | Metadata changed |
| May 8, 2026 | CMS / Medicare | Response to Comments: Epidural Steroid Injections for Pain Management | Metadata changed |
| May 8, 2026 | CMS / Medicare | Transcatheter Infusion Therapy | Metadata changed |
| May 8, 2026 | CMS / Medicare | Response to Comments: Polysomnography and Other Sleep Studies | Metadata changed |
| May 8, 2026 | CMS / Medicare | Response to Comments: MolDX: Foodborne Gastrointestinal Panels Identified by Multiplex Nucleic Acid Amplification Tests (NAATs) (DL37766) | Metadata changed |
| May 8, 2026 | CMS / Medicare | Hemorheograph | Metadata changed |
| May 8, 2026 | CMS / Medicare | Response to Comments: Urine Drug Testing | Metadata changed |
| May 8, 2026 | CMS / Medicare | Hospice Alzheimer's Disease & Related Disorders | Metadata changed |
| May 8, 2026 | CMS / Medicare | Response to Comments: Select Minimally Invasive GERD Procedures | Metadata changed |
| May 8, 2026 | CMS / Medicare | Erythropoiesis Stimulating Agents (ESAs) | Metadata changed |
| May 8, 2026 | CMS / Medicare | Response to Comments: MolDX: Molecular Assays for the Diagnosis of Cutaneous Melanoma | Metadata changed |
| May 8, 2026 | CMS / Medicare | Autonomic Function Testing | Metadata changed |
| May 8, 2026 | CMS / Medicare | Non-Invasive Fractional Flow Reserve (FFR) for Ischemic Heart Disease | Metadata changed |
| May 8, 2026 | CMS / Medicare | MolDX: Molecular Testing for Solid Organ Allograft Rejection | Metadata changed |
| May 8, 2026 | CMS / Medicare | Response to Comments: Nerve Conduction Studies and Electromyography | Metadata changed |
| May 8, 2026 | CMS / Medicare | Response to Comments: Peroral Endoscopic Myotomy (POEM) | Metadata changed |
| May 8, 2026 | CMS / Medicare | Artificial Intelligence Enabled CT Based Quantitative Coronary Topography (AI-QCT)/Coronary Plaque Analysis (AI-CPA) | Metadata changed |
| May 8, 2026 | CMS / Medicare | Allergy Testing | Metadata changed |
| May 8, 2026 | CMS / Medicare | MolDX: Genetic Testing for Heritable Thoracic Aortic Disease | Metadata changed |
| May 8, 2026 | CMS / Medicare | Osteogenic Stimulators | Metadata changed |
| May 8, 2026 | CMS / Medicare | Vitrectomy | Metadata changed |
| May 8, 2026 | CMS / Medicare | Response to Comments: MolDX: Molecular Biomarker Testing for Risk Stratification of Cutaneous Squamous Cell Carcinoma | Metadata changed |
| May 8, 2026 | CMS / Medicare | Home Health Occupational Therapy | Metadata changed |
| May 8, 2026 | CMS / Medicare | Scanning Computerized Ophthalmic Diagnostic Imaging (SCODI) | Metadata changed |
| May 8, 2026 | CMS / Medicare | MolDX: Oncotype DX Breast Cancer for DCIS (Genomic Health) | Metadata changed |
| May 8, 2026 | CMS / Medicare | Response to Comments: Molecular Pathology Procedures | Metadata changed |
| May 8, 2026 | CMS / Medicare | Response to Comments: Transurethral Waterjet Ablation of the Prostate (L38682) | Metadata changed |
| May 8, 2026 | CMS / Medicare | Response to Comments: MolDX: EndoPredict® Breast Cancer Gene Expression Test | Metadata changed |
| May 8, 2026 | CMS / Medicare | Multiple Electroconvulsive Therapy (MECT) | Metadata changed |
| May 8, 2026 | CMS / Medicare | Screening for the Human Immunodeficiency Virus (HIV) Infection | Metadata changed |
| May 8, 2026 | CMS / Medicare | Blood Transfusions | Metadata changed |
| May 8, 2026 | CMS / Medicare | Response to Comments: External Infusion Pumps â DL33794 | Metadata changed |
| May 8, 2026 | CMS / Medicare | MolDX: Molecular Diagnostic Tests (MDT) | Metadata changed |
| May 8, 2026 | CMS / Medicare | Ophthalmic Angiography (Fluorescein and Indocyanine Green) | Metadata changed |
| May 8, 2026 | CMS / Medicare | MolDX: NRAS Genetic Testing | Metadata changed |
| May 8, 2026 | CMS / Medicare | Response to Comments: Off-label Use of Rituximab and Rituximab Biosimilars | Metadata changed |
| May 8, 2026 | CMS / Medicare | Peripheral Nerve Blocks | Metadata changed |
| May 8, 2026 | CMS / Medicare | Allogeneic Hematopoietic Cell Transplantation for Primary Refractory or Relapsed Hodgkin's and Non-Hodgkin's Lymphoma with B-cell or T-cell Origin | Metadata changed |
| May 8, 2026 | CMS / Medicare | MolDX: Oncotype DX Breast Cancer for DCIS (Genomic Health) | Metadata changed |
| May 8, 2026 | CMS / Medicare | Response to Comments: Amniotic and Placental Derived Product Injections and/or Applications for Musculoskeletal Indications, Non-Wound | Metadata changed |
| May 8, 2026 | CMS / Medicare | Lab: Special Histochemical Stains and Immunohistochemical Stains | Metadata changed |
| May 8, 2026 | CMS / Medicare | Superficial Radiation Therapy (SRT) for the Treatment of Nonmelanoma Skin Cancers (NMSC) | Metadata changed |